These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33170949)

  • 1. Multi-Agency Development of Medical Countermeasures Against Opioid-Induced Respiratory Depression.
    Throckmorton DC; Volkow N; Platoff G; Amaya K; Laney J
    Clin Pharmacol Ther; 2021 Mar; 109(3):576-577. PubMed ID: 33170949
    [No Abstract]   [Full Text] [Related]  

  • 2. Countermeasures for Preventing and Treating Opioid Overdose.
    France CP; Ahern GP; Averick S; Disney A; Enright HA; Esmaeli-Azad B; Federico A; Gerak LR; Husbands SM; Kolber B; Lau EY; Lao V; Maguire DR; Malfatti MA; Martinez G; Mayer BP; Pravetoni M; Sahibzada N; Skolnick P; Snyder EY; Tomycz N; Valdez CA; Zapf J
    Clin Pharmacol Ther; 2021 Mar; 109(3):578-590. PubMed ID: 33113208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019.
    Yeung DT; Bough KJ; Harper JR; Platoff GE
    J Med Toxicol; 2020 Jan; 16(1):87-105. PubMed ID: 31853736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA Experience With Regulation of Naloxone Products to Address the Opioid Crisis and Opportunities for Leveraging Scientific Engagement.
    Amur S; Xu Y; Hertz S; Clingman C
    Clin Pharmacol Ther; 2021 Mar; 109(3):569-572. PubMed ID: 33241562
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of an Unsanctioned Safe Consumption Site in the United States.
    Kral AH; Lambdin BH; Wenger LD; Davidson PJ
    N Engl J Med; 2020 Aug; 383(6):589-590. PubMed ID: 32640126
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk Stratification for Naloxone Rescue Kit Interventions at a Veterans Affairs Teaching Hospital.
    Rozea HN; Mitchell BG; Miller LJ
    J Clin Psychopharmacol; 2020; 40(5):513-515. PubMed ID: 32796390
    [No Abstract]   [Full Text] [Related]  

  • 7. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
    Balhara YP
    J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101
    [No Abstract]   [Full Text] [Related]  

  • 8. Patterns of naloxone use in hospitalized patients.
    Yung L; Lee KC; Hsu C; Furnish T; Atayee RS
    Postgrad Med; 2017 Jan; 129(1):40-45. PubMed ID: 27858510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ensure global access to naloxone for opioid overdose management.
    Balster RL; Walsh SL
    Addiction; 2016 Apr; 111(4):589-90. PubMed ID: 26995171
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of Delayed Postoperative Respiratory Depression Assessed from Naloxone Administration.
    Weingarten TN; Herasevich V; McGlinch MC; Beatty NC; Christensen ED; Hannifan SK; Koenig AE; Klanke J; Zhu X; Gali B; Schroeder DR; Sprung J
    Anesth Analg; 2015 Aug; 121(2):422-9. PubMed ID: 25993390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rhode Island community responds to opioid overdose deaths.
    Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M
    R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combative Treatment for Carfentanil Epidemic.
    Konapur R; Searls N; Babcock CCK; Blough E; Patel I
    J Addict Nurs; 2019; 30(1):2-3. PubMed ID: 30829994
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxone.
    Boland J; Boland E; Brooks D
    Clin Med (Lond); 2013 Apr; 13(2):149-51. PubMed ID: 23681862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OVERDOSED ON OPIOIDS: A deadly opioid epidemic sweeping the country has lawmakers working hard to find solutions.
    Hoback J
    State Legis; 2016 Apr; 42(4):9-13. PubMed ID: 27071212
    [No Abstract]   [Full Text] [Related]  

  • 15. FIGHTING THE OPIOID CRISIS FROM THE FRONT LINE. How EMS can share data and partner with public health to help combat the overdose epidemic.
    Kinsman JM; Elder JM; Kanter JM
    EMS World; 2016 Oct; 45(10):25-8, 30-2, 34. PubMed ID: 29953755
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of Opioid-Induced Ventilatory Depression Using Low-Dose Naloxone (0.04 mg): a Case Series.
    Kim HK; Nelson LS
    J Med Toxicol; 2016 Mar; 12(1):107-10. PubMed ID: 26289651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone treatment in opioid addiction: the risks and benefits.
    van Dorp E; Yassen A; Dahan A
    Expert Opin Drug Saf; 2007 Mar; 6(2):125-32. PubMed ID: 17367258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solving the Opioid Crisis: Respiratory Depression by Opioids as Critical End Point.
    Montandon G; Slutsky AS
    Chest; 2019 Oct; 156(4):653-658. PubMed ID: 31194974
    [No Abstract]   [Full Text] [Related]  

  • 19. Findings of a Naloxone Database and its Utilization to Improve Safety and Education in a Tertiary Care Medical Center.
    Rosenfeld DM; Betcher JA; Shah RA; Chang YH; Cheng MR; Cubillo EI; Griffin JM; Trentman TL
    Pain Pract; 2016 Mar; 16(3):327-33. PubMed ID: 25564757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment.
    Raheemullah A; Lembke A
    JAMA Intern Med; 2019 Mar; 179(3):427-428. PubMed ID: 30640372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.